Solventum Corp (SOLV) stock
SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3092% above fair value
$88.81+0.19 (+0.21%)
Close on Nov 12, 2026Market cap $15.12BP/E 99.8Yield –
Solventum EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Solventum's EV/EBITDA was 7.6× on Nov 11, 2026, against 6.7× a year earlier. Over the last 2 years it ranged from 5.8× to 15.3×, with a median of 9.3×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 7.6× | +1.3 |
| 2025 | Dec 31, 2025 | 6.4× | −3.8 |
| 2024 | Dec 31, 2024 | 10.1× | – |
See a number that looks wrong?